marijuana stock news

Form 8-K for NUVILEX, INC.

9-Jan-2015

Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disc

Item 5.03 Amendments to Articles of Incorporation or BylawsEffective January 6, 2015, Nuvilex, Inc. (“Company”) changed its legal corporate name to “PharmaCyte Biotech, Inc.” The name change was effected through a short-form merger pursuant to Section 92A.180 of the Nevada Revised Statutes. A wholly-owned subsidiary of the Company was merged with and into the Company, with the Company as the surviving entity of the merger. The merger had the effect of amending the Company’s Certificate of Incorporation to reflect the new legal name of the Company. A copy of the Articles of Merger effecting the name change, as filed with the Secretary of State of the State of Nevada, is attached hereto as Exhibit 3.1. The Articles of Merger became effective by their terms on January 6, 2015.

In connection with the name change, the Company also changed the ticker symbol of its common stock, which previously traded under the ticker symbol “NVLX.” The Company’s common stock is trading under the ticker symbol “PMCB.”

The merger and resulting name change do not affect the rights of the Company’s security holders, creditors, customers or suppliers. With the exception of the name change, there were no changes to the Company’s Certificate of Incorporation or Bylaws.

Item 7.01. Regulation FD DisclosureOn January 7, 2015, the Company issued a press release announcing the name change, a copy of which is attached hereto as Exhibit 99.1. On January 8, 2015, the Company issued a press release announcing the new ticker symbol, a copy of which is attached hereto as Exhibit 99.2. The information furnished in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

3.1 Articles of Merger merging PharmaCyte Biotech, Inc. with and into Nuvilex, Inc., effective January 6, 2015
99.1 Press Release dated January 7, 2015
99.2 Press Release dated January 8, 2015


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Charlotte’s Web Holdings, Inc. (CWBHF) Hemp CBD Topical Products Expanding to 1,350 Kroger Stores Across 22 States

Charlotte’s Web Hemp CBD Topical Products Expanding to 1,350 Kroger Stores Across…

$MDBX is Now on Equity Alert With Securities Class Action in Motion

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Against…

Curaleaf Holdings, Inc. (CURLF) to Report Third Quarter 2024 Financial and Operational Results

Curaleaf to Report Third Quarter 2024 Financial and Operational Results Curaleaf Holdings,…

$RSSFF Cancels Agreement with Sigorex

Affinor Cancels Investor Relations Agreement with Sigorex MONTREAL, QUEBEC–(Marketwired – Dec 1,…